Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: A naturalistic comparison study

Journal of Affective Disorders

Volumn 113, Issue 1-2, 2009, Pages 165-171

  Eranti, Savithasri V ^a   Mogg, Andrew J ^a   Pluck, Graham C ^a   Landau, Sabine ^a   McLoughlin, Declan M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anaesthesia; Depression; ECT; Etomidate; Methohexitone; Propofol

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETOMIDATE; LITHIUM; METHOHEXITAL; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; PROPOFOL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; AMNESIA; ARTICLE; COMPARATIVE STUDY; CONFUSION; CONTROLLED STUDY; COST; DISEASE DURATION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; SAMPLE SIZE; SEIZURE; STIMULUS; TREATMENT RESPONSE;

AGED; ANESTHETICS, INTRAVENOUS; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; ETOMIDATE; FEMALE; HUMANS; MALE; METHOHEXITAL; MIDDLE AGED; PROPOFOL;

EID: 58149097072     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.03.004     Document Type: Article

References (31)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. (DSM-IV) (1994), American Psychiatric Association, Washington, DC
2. American Psychiatric Association Committee on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging (2001), American Psychiatric Association, Washington, DC
3. Avramov M.N., Husain M.M., and White P.F. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia 81 3 (1995) 596-602
4. Bailine S.H., Petrides G., Doft M., and Lui G. Indications for the use of propofol in electroconvulsive therapy. Journal of ECT 19 3 (2003) 129-132
5. Benbow S.M., Shah P., and Crentsil J. Anaesthesia for electroconvulsive therapy: a role for etomidate. Psych Bulletin 26 (2002) 351-353
6. Datto C., Rai A.K., Ilivicky H.J., and Caroff S.N. Augmentation of seizure induction in electroconvulsive therapy: a clinical reappraisal. Journal of ECT 18 3 (2002) 118-125
7. Ding Z., and White P.F. Anesthesia for electroconvulsive therapy. Anesthesia and Analgesia 94 5 (2002) 1351-1364
8. Eranti S., Mogg A., Pluck G., Landau S., Purvis R., Brown R.G., Howard R., Knapp M., Philpot M., Rabe-Hesketh S., Romeo R., Rothwell J., Edwards D., and McLoughlin D.M. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. American Journal of Psychiatry 164 (2007) 73-81
9. Geretsegger C., Rochowanski E., Kartnig C., and Unterrainer A.F. Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT ): a comparison of seizure-quality measures and vital signs. Journal of ECT 14 1 (1998) 28-35
10. Gran L., Bergsholm P., and Bleie H. Seizure duration in unilateral electroconvulsive therapy - a comparison of the anesthetic agents etomidate and Althesin with methohexitone. Acta Psychiatrica Scandinavica 69 6 (1984) 472-483
11. Kadoi Y., Saito S., Ide M., Toda H., Sekimoto K., Seki S., Takahashi K., and Goto F. The comparative effects of propofol versus thiopentone on left ventricular function during electroconvulsive therapy. Anaesthesia and Intensive Care 31 2 (2003) 172-175
12. Khalid N., Atkins M., and Kirov G. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. Journal of ECT 22 3 (2006) 184-188
13. Kovac A.L., and Pardo M. A comparison between etomidate and methohexital for anesthesia in ECT. Convulsive Theraputic 8 2 (1992) 118-125
14. Leung M., Hollander Y., and Brown G.R. Pretreatment with ibuprofen to prevent electroconvulsive therapy-induced headache. Journal of Clinical Psychiatry 64 5 (2003) 551-553
15. McGuffin P., Farmer A., and Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness - development and reliability of the OPCRIT system. Archives of General Psychiatry 48 8 (1991) 764-770
16. McLoughlin D.M., Mogg A., Eranti S., Pluck G., Purvis R., Edwards D., Landau S., Brown R., Rabe-Hesketh S., Howard R., Philpot M., Rothwell J., Romeo R., and Knapp M. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis. Health Technology Assessment 11 24 (2007) 1-54
17. Morris C., and McAllister C. Etomidate for emergency anaesthesia; mad, bad and dangerous to know?. Anaesthesia 60 8 (2005) 737-740
18. Patel A.S., Gorst-Unsworth C., Venn R.M., Kelley K., and Jacob Y. Anesthesia and electroconvulsive therapy: a retrospective study comparing etomidate and propofol. Journal of ECT 22 3 (2006) 179-183
19. Royal College of Psychiatrists. The ECT handbook: the third report of the Royal College of Psychiatrists' Special Committee on ECT. Council Report CR128 (2005), Royal College of Psychiatrists, London
20. Royal College of Psychiatrists. The ECT handbook: the second report of the Royal College of Psychiatrists' Special Committee on ECT. Council Report CR39 (1995), Royal College of Psychiatrists, London
21. Royal College of Psychiatrists' Special Committee on ECT. Guidelines for ECT anaesthesia. Psych. Bull. 26 (2002) 237-238
22. Sackeim H.A., Prudic J., Devanand D.P., Kiersky J.E., Fitzsimons L., Moody B.J., Mcelhiney M.C., Coleman E.A., and Settembrino J.M. Effects of stimulus-intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive-therapy. New England Journal of Medicine 328 (1993) 839-846
23. Sackeim H.A., Ross F.R., Hopkins N., Calev L., and Devanand D.P. Subjective side effects acutely following ECT: associations with treatment modality and clinical response. Convulsive Theraputic 3 (1987) 100-110
24. Scott A., and Boddy H. Induction agents in electroconvulsive therapy: a comparison of methohexitone and propofol. Psych Bulletin 26 (2002) 455-457
25. Swaim J.C., Mansour M., Wydo S.M., and Moore J.L. A retrospective comparison of anaesthetic agents in electroconvulsive therapy. Journal of ECT 22 (2006) 243-246
26. Swartz C.M., and Abrams R. ECT Instruction Manual. Somatics Inc., Lake Bluff, Illinois (1996)
27. Tecoult E., and Nathan N. Morbidity in electroconvulsive therapy. European Journal Of Anaesthesiology 18 8 (2001) 511-518
28. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361 9360 (2003) 799-808
29. Wagner K.J., Mollenberg O., Rentrop M., Werner C., and Kochs E.F. Guide to anaesthetic selection for electroconvulsive therapy. CNS Drugs 19 9 (2005) 745-758
30. Walder B., Seeck M., and Tramer M.R. Propfol versus methohexital for electroconvulsive therapy - a meta-analysis. Journal Of Neurosurgical Anesthesiology 13 2 (2001) 93-98
31. Williams R.L. A note on robust variance estimation for cluster-correlated data. Biometrics 56 2 (2000) 645-646